You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 539 Phase 1 study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L/IL-23/IL-36γ, for intratumoral (ITu) injection +/- durvalumab in advanced solid tumors and lymphoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
539 Phase 1 study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L/IL-23/IL-36γ, for intratumoral (ITu) injection +/- durvalumab in advanced solid tumors and lymphoma
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to October 2024

AbstractFullPdf
Nov 2021437037
Dec 2021198018
Jan 2022124013
Feb 2022130035
Mar 2022256026
Apr 2022204026
May 2022172051
Jun 2022164048
Jul 2022188021
Aug 2022226028
Sep 2022168027
Oct 2022160023
Nov 2022336028
Dec 2022250023
Jan 2023320040
Feb 2023216017
Mar 2023234022
Apr 2023226023
May 2023300027
Jun 2023324040
Jul 2023362046
Aug 2023269037
Sep 2023382052
Oct 2023324033
Nov 2023314033
Dec 2023242024
Jan 2024108012
Feb 2024124023
Mar 2024320037
Apr 2024420049
May 2024328031
Jun 2024250021
Jul 2024336040
Aug 2024358030
Sep 2024516053
Oct 2024272036
Total955801130